Equillium (NASDAQ:EQ) Inc CEO Bruce Steele joined Steve Darling from Proactive to talk more about the company that has a mission to develop therapeutics to treat severe autoimmune and inflammatory disorders.Steele talks more about the company’s proprietary multi-cytokine platform. Steele also talked about its pipeline and the numerous drugs in production.
Equillium looking to battle unmet needs to treat severe autoimmune and inflammatory disorders
